José Valentín
García Gutiérrez
Profesor/a Asociado/a en CC. de la Salud
Hospital General Universitario de Alicante
Alicante, EspañaPublicacions en col·laboració amb investigadors/es de Hospital General Universitario de Alicante (12)
2024
-
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
Annals of Hematology, Vol. 103, Núm. 11, pp. 4537-4544
-
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Leukemia
2023
2022
-
Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH
Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 770-783
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
-
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Cancer, Vol. 128, Núm. 13, pp. 2441-2448
2021
-
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia
British Journal of Haematology, Vol. 192, Núm. 6, pp. 988-996
-
Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea
Leukemia, Vol. 35, Núm. 2, pp. 623-627
-
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice
Blood Cancer Journal
2020
-
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk
Leukemia, Vol. 34, Núm. 10, pp. 2648-2659
2018
-
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
Blood Cancer Journal, Vol. 8, Núm. 10
2017
-
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea
Haematologica, Vol. 102, Núm. 1, pp. 103-109